Association of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and parathyroid hormone with mortality among middle-aged and older European men

Age and Ageing

Volumn 43, Issue 4, 2014, Pages 528-535

  Lee, David M ^a,o   Vanderschueren, Dirk ^b,o   Boonen, Steven ^b,o   O'Neill, Terence W ^c,o   Pendleton, Neil ^d,o   Pye, Stephen R ^c,o   Ravindrarajah, Rathi ^e   Gielen, Evelien ^b   Claessens, Frank ^b   Bartfai, György ^f,o   Casanueva, Felipe F ^g,o   Finn, Joseph D ^e,o   Forti, Gianni ^h,o   Giwercman, Aleksander ^i,o   Han, Thang S ^j   Huhtaniemi, Ilpo T ^k,o   Kula, Krzysztof ^l,o   Lean, Michael E J ^m   Punab, Margus ^n,o   Wu, Frederick C W ^e,o   Petrone, Luisa ^o   Corona, Giovanni ^o   Borghs, Herman ^o   Slowikowska Hilczer, Jolanta ^o   Walczak Jedrzejowska, Renata ^o   Steer, Philip ^o   Carter, Emma ^o   Castro, Ana I ^o   Földesi, Imre ^o   Fejes, Imre ^o   Korrovitz, Paul ^o   Jiang, Min ^o   more..

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

^f UNIVERSITY OF SZEGED   (Hungary)

^g UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^h UNIVERSITY OF FLORENCE   (Italy)

ⁱ LUND UNIVERSITY HOSPITAL   (Sweden)

^j ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^k IMPERIAL COLLEGE LONDON   (United Kingdom)

^l MEDICAL UNIVERSITY OF LODZ   (Poland)

^m UNIVERSITY OF GLASGOW   (United Kingdom)

ⁿ TARTU UNIVERSITY CLINICS   (Estonia)

^o NONE

more..

Author keywords

1,25 dihydroxyvitamin D; 25 Hydroxyvitamin D; Mortality; Older people; Parathyroid hormone; Population based

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; PARATHYROID HORMONE; 1,25-DIHYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; BIOLOGICAL MARKER; VITAMIN D;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CARDIOVASCULAR MORTALITY; COHORT ANALYSIS; ETHNIC GROUP; EUROPEAN; FUNCTIONAL STATUS; HUMAN; MALE; MIDDLE AGED; MORBIDITY; MORTALITY; PARATHYROID HORMONE BLOOD LEVEL; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SMOKING; VITAMIN BLOOD LEVEL; AGING; ANALOGS AND DERIVATIVES; BLOOD; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; EUROPE; FOLLOW UP; LIFESTYLE; MULTICENTER STUDY; NEOPLASM; QUESTIONNAIRE; REGRESSION ANALYSIS; RISK FACTOR; SURVIVAL RATE;

ADULT; AGED; AGING; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; COHORT STUDIES; EUROPE; FOLLOW-UP STUDIES; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; NEOPLASMS; PARATHYROID HORMONE; PROSPECTIVE STUDIES; QUESTIONNAIRES; REGRESSION ANALYSIS; RISK FACTORS; SURVIVAL RATE; VITAMIN D;

EID: 84903208578     PISSN: 00020729     EISSN: 14682834     Source Type: Journal    
DOI: 10.1093/ageing/aft206     Document Type: Article

References (36)

1. Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 2006; 81: 353-73.
2. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 2001; 22: 477-501.
3. Jones G, Strugnell SA, DeLuca HF. Current understanding of the molecular actions of vitamin D. Physiol Rev 1998; 78: 1193-231.
4. Llewellyn DJ, Lang IA, Langa KM et al. Vitamin D and risk of cognitive decline in elderly persons. Arch Intern Med 2010; 170: 1135-41.
5. Wang L, Manson JE, Song Y, Sesso HD. Systematic review: vitamin D and calcium supplementation in prevention of cardiovascular events. Ann Intern Med 2010; 152: 315-23.
6. Lee DM, Tajar A, O'Neill TWet al. Lower vitamin D levels are associated with depression among community-dwelling European men. J Psychopharmacol 2011; 25: 1320-8.
7. Pilz S, Kienreich K, Rutters F et al. Role of vitamin D in the development of insulin resistance and type 2 diabetes. Curr Diab Rep 2013; 13: 261-70.
8. Churilla TM, Brereton HD, Klem M, Peters CA. Vitamin D deficiency is widespread in cancer patients and correlates with advanced stage disease: a community oncology experience. Nutr Cancer 2012; 64: 521-5.
9. Autier P, Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med 2007; 167: 1730-7.
10. Bjelakovic G, Gluud LL, Nikolova D et al. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev 2011:CD007470.
11. Rejnmark L, Avenell A, Masud T et al. Vitamin D with calcium reduces mortality: patient level pooled analysis of 70,528 patients from eight major vitamin D trials. J Clin Endocrinol Metab 2012; 97: 2670-81.
12. Schottker B, Ball D, Gellert C, Brenner H. Serum 25-hydroxyvitamin D levels and overall mortality. A systematic review and meta-analysis of prospective cohort studies. Ageing Res Rev 2013; 12: 708-718.
13. Zittermann A, Iodice S, Pilz S, Grant WB, Bagnardi V, Gandini S. Vitamin D deficiency and mortality risk in the general population: a meta-analysis of prospective cohort studies. Am J Clin Nutr 2012; 95: 91-100.
14. Manson JE, Mayne ST, Clinton SK. Vitamin D and prevention of cancer-ready for prime time? N Engl J Med 2011; 364: 1385-7.
15. Pilz S, Kienreich K, Tomaschitz A et al. Vitamin d and cancer mortality: systematic review of prospective epidemiological studies. Anticancer Agents Med Chem 2013; 13: 107-17.
16. Pilz S, Tomaschitz A, Marz Wet al. Vitamin D, cardiovascular disease and mortality. Clin Endocrinol (Oxf) 2011; 75: 575-84.
17. Dobnig H, Pilz S, Scharnagl H et al. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med 2008; 168: 1340-9.
18. Sambrook PN, Chen JS, March LM et al. Serum parathyroid hormone is associated with increased mortality independent of 25-hydroxy vitamin d status, bone mass, and renal function in the frail and very old: a cohort study. J Clin Endocrinol Metab 2004; 89: 5477-81.
19. Hagstrom E, Hellman P, Larsson TE et al. Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation 2009; 119: 2765-71.
20. Lee DM, O'Neill TW, Pye SR et al. The European Male Ageing Study (EMAS): design, methods and recruitment. Int J Androl 2009; 32: 11-24.
21. Washburn RA, Smith KW, Jette AM, Janney CA. The Physical Activity Scale for the Elderly (PASE): development and evaluation. J Clin Epidemiol 1993; 46: 153-62.
22. Reuben DB, Siu AL. An objective measure of physical function of elderly outpatients. The Physical Performance Test. J Am Geriatr Soc 1990; 38: 1105-12.
23. Casetta B, Jans I, Billen J, Vanderschueren D, Bouillon R. Development of a method for the quantification of 1alpha,25 (OH)2-vitamin D3 in serum by liquid chromatography tandem mass spectrometry without derivatization. Eur J Mass Spectrom (Chichester, Eng) 2010; 16: 81-9.
24. Vanderschueren D, Pye SR, O'Neill TWet al. Active vitamin D (1,25-dihydroxyvitamin D) and bone health in middle-aged and elderly men: the European Male Aging Study (EMAS). J Clin Endocrinol Metab 2013; 98: 995-1005.
25. Blass KG, Thibert RJ, Lam LK. A study of the mechanism of the Jaffe reaction. Z Klin Chem Klin Biochem 1974; 12: 336-43.
26. Ross AC, Manson JE, Abrams SA et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011; 96: 53-8.
27. Survival Analysis with Stata. UCLA: Statistical Consulting Group http://www.ats.ucla.edu/stat/stata/seminars/stata_ survival/#proportionality (16 September 2013, date last accessed).
28. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94: 496-509.
29. Schottker B, Haug U, Schomburg L et al. Strong associations of 25-hydroxyvitamin D concentrations with all-cause, cardiovascular, cancer, and respiratory disease mortality in a large cohort study. Am J Clin Nutr 2013; 97: 782-93.
30. Kendrick J, Cheung AK, Kaufman JS et al. Associations of plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D concentrations with death and progression to maintenance dialysis in patients with advanced kidney disease. Am J Kidney Dis 2012; 60: 567-75.
31. Freedman DM, Looker AC, Chang SC, Graubard BI. Prospective study of serum vitamin D and cancer mortality in the United States. J Natl Cancer Inst 2007; 99: 1594-602.
32. Tajar A, Lee DM, Pye SR et al. The association of frailty with serum 25-hydroxyvitamin D and parathyroid hormone levels in older European men. Age Ageing 2013; 42: 352-9.
33. Lee DM, Tajar A, Ulubaev A et al. Association between 25-hydroxyvitamin D levels and cognitive performance in middle-aged and older European men. J Neurol Neurosurg Psychiatry 2009; 80: 722-9.
34. Lee DM, Rutter MK, O'Neill TWet al. Vitamin D, parathyroid hormone and the metabolic syndrome in middle-aged and older European men. Eur J Endocrinol 2009; 161: 947-54.
35. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266-81.
36. Thacher TD, Clarke BL. Vitamin D insufficiency. Mayo Clin Proc 2011; 86: 50-60.